At its 2020 annual meeting, the National Academy of Medicine (NAM) announced the election of 90 regular members, including Carlos Zarate Jr. of the National Institute of Mental Health (NIMH). The election to the academy is one of the highest awards in the fields of health and medicine and recognizes outstanding professional achievements and commitment to service.
Dr. Zarate is Head of the Experimental Therapeutics and Pathophysiology Division of the NIMH Intramural Research Program, where his research focuses on the development of novel drugs for treatment-resistant depression and bipolar disorder. Dr. Zarate’s research helped determine that a single infusion of ketamine can rapidly reduce depressive symptoms in people with treatment-resistant depression or bipolar depression. The identification of ketamine as a fast-acting intervention for depression has given hope to the many people for whom traditional depression treatments are not effective.
Dr. Zarate received his MD from the Catholic University of Cordoba in 1985. From 1992 to 1993 he completed a fellowship in clinical psychopharmacology at McLean Hospital. He then stayed with the company until 1998. Consolidated at McLean Hospital The Department of Psychiatry at Harvard Medical School, Dr. Zarate, was director of the Outpatient Clinic for Bipolar and Psychotic Disorders, Chairman of the Committee on Pharmacy and Therapy, and Director of the new and experimental clinic. From 1998 to 2000, Dr. Zarate Chief of Bipolar and Psychotic Disorders Program, Associate Professor of Psychiatry, and Chairman of the Grand Rounds Committee at the University of Massachusetts Medical School. In January 2001, he joined the NIMH’s Mood and Anxiety Disorders Program at the NIMH as Head of Mood Disorders Research. In 2009, Dr. Zarate the Department of Experimental Therapeutics and Pathophysiology at the NIMH.
Dr. Zarate received several previous awards including the Massachusetts Psychiatric Association’s Outstanding Psychiatrist Research Award; the Brain Behavior Research Foundation award for research into bipolar mood disorders; and numerous awards from NIMH and the National Institutes of Health for mentoring, supervision, and outstanding scientific contributions.